Exhibit 32.2


              CERTIFICATION OF CHIEF FINANCIAL OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the IGENE Biotechnology, Inc. (the "Company")
Quarterly Report on Form 10-Q for the period ended June 30,  2010  as
filed with the Securities and Exchange Commission (the "Report"),  I,
Edward J. Weisberger, Chief Financial Officer of the Company, certify
pursuant  to 18 U.S.C. Section 1350, as adopted pursuant  to  Section
906  of  the  Sarbanes-Oxley Act of 2002, that, to  the  best  of  my
knowledge:

          (1).  The  Report  fully complies with the requirements  of
          Section  13(a) or 15(d) of the Securities Exchange  Act  of
          1934, as amended; and

          (2).   The  information  contained  in  the  Report  fairly
          presents, in all material respects, the financial condition
          and results of operations of the Company.


Date: August 13, 2010                By:  /S/ EDWARD J. WEISBERGER
                                          ___________________________
                                              EDWARD J. WEISBERGER
                                              Chief Financial Officer


A  signed original of this written statement required by Section  906
has  been provided to the Company and will be retained by the Company
and  furnished to the Securities and Exchange Commission or its staff
upon request.